These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 20950304)
41. Sildenafil reduces bother associated with erectile dysfunction: pooled analysis of five randomized, double-blind trials. Seftel AD; Creanga DL; Levinson IP Int J Impot Res; 2007; 19(6):584-90. PubMed ID: 17611607 [TBL] [Abstract][Full Text] [Related]
42. Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction. Ishii N; Nagao K; Fujikawa K; Tachibana T; Iwamoto Y; Kamidono S Int J Urol; 2006 Aug; 13(8):1066-72. PubMed ID: 16903931 [TBL] [Abstract][Full Text] [Related]
43. [Efficacy and safety of vardenafil in the treatment of erectile dysfunction in men with hypertension]. Li HJ Zhonghua Nan Ke Xue; 2006 Oct; 12(10):953-6. PubMed ID: 17121032 [TBL] [Abstract][Full Text] [Related]
44. Early intervention with phosphodiesterase-5 inhibitors after prostate brachytherapy improves subsequent erectile function. Pahlajani G; Raina R; Jones JS; Burdick M; Ali M; Li J; Mahadevan A; Ciezki J; Zippe C BJU Int; 2010 Nov; 106(10):1524-7. PubMed ID: 20477827 [TBL] [Abstract][Full Text] [Related]
45. [Measures for optimizing the efficacy of sildenafil on patients with erectile dysfunction]. Deng CH; Guo HB Zhonghua Nan Ke Xue; 2005 May; 11(5):389-91. PubMed ID: 15934466 [TBL] [Abstract][Full Text] [Related]
46. The utility of sildenafil citrate for infertile men with sexual dysfunction: a pilot study. Boorjian S; Hopps CV; Ghaly SW; Parker M; Mulhall JP BJU Int; 2007 Sep; 100(3):603-6. PubMed ID: 17590181 [TBL] [Abstract][Full Text] [Related]
47. Sildenafil citrate in the treatment of sexual dysfunction and its effect on quality of life in alcohol dependent men: preliminary findings. Grinshpoon A; Margolis A; Weizman A; Ponizovsky AM Alcohol Alcohol; 2007; 42(4):340-6. PubMed ID: 17537832 [TBL] [Abstract][Full Text] [Related]
48. Association of lower urinary tract symptoms with erectile dysfunction in Japanese men. Terai A; Ichioka K; Matsui Y; Yoshimura K Urology; 2004 Jul; 64(1):132-6. PubMed ID: 15245950 [TBL] [Abstract][Full Text] [Related]
49. Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study. Safarinejad MR; Kolahi AA; Ghaedi G BJU Int; 2009 Aug; 104(3):376-83. PubMed ID: 19389004 [TBL] [Abstract][Full Text] [Related]
50. Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: opening windows to enhanced sexual function and overall health. Sadovsky R; Brock GB; Gray M; Jensen PK; Gutkin SW; Sorsaburu S J Am Acad Nurse Pract; 2011 Jun; 23(6):320-30. PubMed ID: 21649775 [TBL] [Abstract][Full Text] [Related]
51. Randomized, double-blind, crossover trial of sildenafil in men with mild to moderate erectile dysfunction: efficacy at 8 and 12 hours postdose. McCullough AR; Steidle CP; Klee B; Tseng LJ Urology; 2008 Apr; 71(4):686-92. PubMed ID: 18387397 [TBL] [Abstract][Full Text] [Related]
52. Is erectile dysfunction a marker for cardiovascular disease? Kirby M; Jackson G; Betteridge J; Friedli K Int J Clin Pract; 2001 Nov; 55(9):614-8. PubMed ID: 11770359 [TBL] [Abstract][Full Text] [Related]
53. Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing. Kloner RA; Jackson G; Hutter AM; Mittleman MA; Chan M; Warner MR; Costigan TM; Vail GM Am J Cardiol; 2006 Jun; 97(12):1778-84. PubMed ID: 16765134 [TBL] [Abstract][Full Text] [Related]
54. Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. Nehra A; Jackson G; Miner M; Billups KL; Burnett AL; Buvat J; Carson CC; Cunningham GR; Goldstein I; Guay AT; Hackett G; Kloner RA; Kostis J; Montorsi P; Ramsey M; Rosen RC; Sadovsky R; Seftel AD; Vlachopoulos C; Wu FC J Urol; 2013 Jun; 189(6):2031-8. PubMed ID: 23313195 [TBL] [Abstract][Full Text] [Related]
55. Should men with mild erectile dysfunction be closely evaluated for cardiovascular diseases in the Korean population? Cho SY; Son H; Kim SW; Paick JS Aging Male; 2014 Jun; 17(2):81-6. PubMed ID: 24397687 [TBL] [Abstract][Full Text] [Related]
56. Lack of awareness of erectile dysfunction in many men with risk factors for erectile dysfunction. Shabsigh R; Kaufman J; Magee M; Creanga D; Russell D; Budhwani M BMC Urol; 2010 Nov; 10():18. PubMed ID: 21054874 [TBL] [Abstract][Full Text] [Related]
57. A feasibility study comparing pharmacist and physician recommendations for sildenafil treatment. Symonds T; Dean JD; Carr A; Carlsson M; Marfatia A; Schnetzler G J Sex Med; 2011 May; 8(5):1463-71. PubMed ID: 21324090 [TBL] [Abstract][Full Text] [Related]
58. Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study. Kirby MG; Schnetzler G; Zou KH; Symonds T Int J Clin Pract; 2011 Jul; 65(7):797-806. PubMed ID: 21676121 [TBL] [Abstract][Full Text] [Related]
59. Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA. Mulhall JP; Luo X; Zou KH; Stecher V; Galaznik A Int J Clin Pract; 2016 Dec; 70(12):1012-1018. PubMed ID: 28032424 [TBL] [Abstract][Full Text] [Related]